Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes

Oral Oncology

Volumn 36, Issue 3, 2000, Pages 267-271

  Sato, M ^a   Sato, T ^a   Izumo, T ^b   Amagasa, T ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

Author keywords

Cigarette smoking dose; CYP1A1 and GSTM1 genes; Oral SCC; Polymorphism; Susceptibility

Indexed keywords

AMINO ACID; DNA; HEME; ISOLEUCINE; VALINE;

ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; SMOKING;

EID: 0034191901     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00090-1     Document Type: Article

References (18)

1. Sato M., Sato T., Izumo T., Amagasa T. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis. 20:1999;1927-1931.
2. Guengerich F.P., Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol. 4:1991;391-407.
3. Idle J.R. Is environmental carcinogenesis modulated by host polymorphism? Mutat Res. 247:1991;259-266.
4. Nebert D.W. Role of genetics and drug metabolism in human cancer risk. Mutat Res. 247:1991;267-281.
5. Omenn G.S. Future research directions in cancer ecogenetics. Mutat Res. 247:1991;283-291.
6. Nakachi K., Imai K., Hayashi S-I, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res. 53:1993;2994-2999.
7. Hirovonen A., Husgafvel-Pursiainen K., Anttila S., Vanio H. The GSTM1 null genotype as potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis. 14:1993;1479-1481.
8. Kihara M., Kihara M., Noda K. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis. 15:1994;415-418.
9. Anttila S., Luostarinen L., Hirovonen A., Elovaara E., Karjalainen A., Nurminen T., Hayes J.D., Vainio H., Ketterer B. Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymorphism, smoking and asbestos exposure. Cancer Res. 55:1995;3305-3309.
10. Trinza Z., Clayman G.L., Spitz M.R., Briggs K.L., Foepfert H. Glutathione S-transferase genotypes as risk factors for head and neck cancer. Am J Surg. 170:1995;499-501.
11. Hayashi S-I, Watanabe J., Nakachi K., Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme-binding region of the human cytochrome P4501A1 gene. J Biochem. 110:1991;407-411.
12. Seidegård J., Vorachek R., Pero R.W., Pearson W.R. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci. 85:1988;7293-7297.
13. Park J.Y., Muscat J.E., Ren Q., Schantz S.P., Harwick R.D., Stern J.C., Pike V., Richie J.P. Jr., Lazarus P. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev. 6:1997;791-797.
14. McWilliams J.E., Cohen J.I., Henner W.D. Glutathione-S-transferase M1, and T1 deficiencies and head and neck cancer risk. Proc Am Assoc Cancer Res. 37:1996;107.
15. Deakin M., Elder J., Hendrickse C., Peckham D., Baldwin D., Pantin C., Wild N., Leopard P., Bell D.A., Jones P., Duncan H., Brannigan K., Alldersea J., Fryer A.A., Strange R.C. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric, and colorectal cancers. Carcinogenesis (Lond.). 17:1996;881-884.
16. Hayashi S-I, Watanabe J., Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res. 83:1992;866-870.
17. Tanimoto K., Hayashi S-I, Yoshiga K., Ichikawa T. Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncology. 35:1999;191-196.
18. Kawajiri K., Kakachi K., Imai K., Watanabe J. The CYP1A1 gene and cancer susceptibility. Critical Reviews in Oncology, Hematology. 14:1993;77-87.